These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7680892)

  • 21. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral heterogeneity of DNA content in renal cell carcinoma and its prognostic significance.
    Ruiz-Cerdá JL; Hernández M; Sempere A; O'Connor JE; Kimler BF; Jiménez-Cruz F
    Cancer; 1999 Aug; 86(4):664-71. PubMed ID: 10440695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere shortening in renal cell carcinoma.
    Mehle C; Ljungberg B; Roos G
    Cancer Res; 1994 Jan; 54(1):236-41. PubMed ID: 8261445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of renal-cell-carcinoma-related cDNA clones by suppression subtractive hybridization.
    Pitzer C; Stassar M; Zöller M
    J Cancer Res Clin Oncol; 1999; 125(8-9):487-92. PubMed ID: 10480341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of DNA fingerprinting with digoxigenated oligonucleotide probe (CAC)5 to analysis of the genetic variation within Taenia taeniaeformis.
    Okamoto M; Ueda H; Hayashi M; Oku Y; Kurosawa T; Kamiya M
    J Vet Med Sci; 1995 Apr; 57(2):267-72. PubMed ID: 7492644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
    Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
    Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data.
    Junker K; Moravek P; Podhola M; Weirich G; Hindermann W; Janitzky V; Schubert J
    Int J Oncol; 2000 Nov; 17(5):903-8. PubMed ID: 11029490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
    Thrash-Bingham CA; Greenberg RE; Howard S; Bruzel A; Bremer M; Goll A; Salazar H; Freed JJ; Tartof KD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2854-8. PubMed ID: 7708737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
    Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
    Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
    Argani P; Antonescu CR; Couturier J; Fournet JC; Sciot R; Debiec-Rychter M; Hutchinson B; Reuter VE; Boccon-Gibod L; Timmons C; Hafez N; Ladanyi M
    Am J Surg Pathol; 2002 Dec; 26(12):1553-66. PubMed ID: 12459622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma.
    Ljungberg B; Nordenson I; Roos G
    Eur Urol; 1991; 19(1):59-64. PubMed ID: 2007420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular characterization of human renal cell carcinoma cell lines.
    Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas.
    Nagy A; Wilhelm M; Sükösd F; Ljungberg B; Kovacs G
    Genes Chromosomes Cancer; 2002 Nov; 35(3):256-60. PubMed ID: 12353267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA fingerprinting with oligonucleotides can differentiate cell lines derived from the same tumor.
    Speth C; Epplen JT; Oberbäumer I
    In Vitro Cell Dev Biol; 1991 Aug; 27A(8):646-50. PubMed ID: 1917782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes.
    Li J; Protopopov A; Wang F; Senchenko V; Petushkov V; Vorontsova O; Petrenko L; Zabarovska V; Muravenko O; Braga E; Kisselev L; Lerman MI; Kashuba V; Klein G; Ernberg I; Wahlestedt C; Zabarovsky ER
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10724-9. PubMed ID: 12149436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
    Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of DNA index in renal-cell carcinoma.
    Devonec M; Bringuier PP; Hijazi A; Dutrieux-Berger N; Revillard JP; Perrin P
    Prog Clin Biol Res; 1990; 348():35-48. PubMed ID: 2385607
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.